Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wegovy
Fierce Pharma
Novo's longtime CEO Lars Fruergaard Jørgensen to step down
It’s the end of an era at Novo as longtime CEO Lars Fruergaard Jørgensen—who shepherded the company through its GLP-1 growth boom—heads for the exit.
Fraiser Kansteiner
May 16, 2025 9:41am
'All hands on deck' at Lilly as peers target obesity market
Aug 8, 2024 1:40pm
Viking to charge quickly into phase 3 with obesity med
Jul 25, 2024 9:19am
The most valuable R&D projects? You guessed it: obesity
Jul 11, 2024 5:00am
Novo Nordisk Foundation inks R&D pact for global health issues
May 6, 2024 10:59am
UPDATE: Amgen axes an obesity asset, zooms in on MariTide
May 2, 2024 6:16pm
